Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity

QR Code

Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotoxicity

Bibliographic Details
Main Authors:	Taddei, K., Laws, S., Verdile, Giuseppe, Munns, S., D'Costa, K., Harvey, A., Martins, I.j, Hill, F., Levy, E., Shaw, J., Martins, R.
Format:	Journal Article
Published:	Elsevier Inc. 2010
Online Access:	http://hdl.handle.net/20.500.11937/26641

Similar Items

A yeast model for studying intracellular clearance of beta-amyloid 42
by: Bharadwaj, Prashant, et al.
Published: (2012)

Validation and characterisation of a novel peptide that binds monomeric and aggregated beta-amyloid and inhibits the formation of neurotoxic oligomers
by: Barr, R., et al.
Published: (2015)

The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism
by: Verdile, Giuseppe, et al.
Published: (2009)

The Effects of Latrepirdine on Amyloid-ß Aggregation and Toxicity
by: Porter, T., et al.
Published: (2016)

The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
by: Verdile, Giuseppe, et al.
Published: (2007)

Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: Elaskalani, O., et al.
Published: (2017)

Effects of latrepirdine on Aß clearance, neurotoxicity and aggregation
by: Martins, R., et al.
Published: (2010)

Distinct Effects of Testosterone on Plasma and Cerebrospinal Fluid Amyloid-ß Levels
by: Wahjoepramono, E., et al.
Published: (2008)

Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels
by: Wahjoepramono, E., et al.
Published: (2011)

Modulation of amyloid-ß 1-42 structure and toxicity by proline-rich whey peptides
by: Bharadwaj, Prashant, et al.
Published: (2013)

Ovariectomy and 17ß-estradiol replacement do not alter ß-amyloid levels in sheep brain
by: Barron, A., et al.
Published: (2009)

Asymptomatic neurotoxicity of amyloid Î-peptides AÎ1-42 and AÎ25-35 on mouse embryonic stem cell-derived neural cells
by: Mansor, Nur Izzati, et al.
Published: (2021)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)

Asymptomatic neurotoxicity of amyloid β-peptides (Aβ1-42 and Aβ25-35) on mouse embryonic stem cell-derived neural cells
by: Mansor, Nur Izzati, et al.
Published: (2020)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

Is Cholesterol and Amyloid-[beta] Stress Induced CD147 Expression a Protective Response? Evidence that Extracellular Cyclophilin A Mediated Neuroprotection is Reliant on CD147
by: Kanyenda, L., et al.
Published: (2014)

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
by: Asih, P., et al.
Published: (2014)

Thymoquinone prevents β-amyloid neurotoxicity in primary cultured cerebellar granule neurons
by: Ismail, Norsharina, et al.
Published: (2013)

Plasma Aß42 correlates positively with increased body fat in healthy individuals
by: Balakrishnana, K., et al.
Published: (2005)

The impact of luteinizing hormone and testosterone on beta amyloid (Aß) accumulation: Animal and human clinical studies
by: Verdile, Giuseppe, et al.
Published: (2015)

Effect of chronic hCG administration on Alzheimer's-related cognition and Aß accumulation in PS1KI mice
by: Barron, A., et al.
Published: (2010)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

Amyloid-ß and islet amyloid pathologies link Alzheimer disease and type 2 diabetes in a transgenic model.
by: Wijesekara, N., et al.
Published: (2017)

Erratum: Clearance mechanisms of Alzheimer's amyloid-? peptide: Implications for therapeutic design and diagnostic tests (Molecular Psychiatry (2009) 14 (469-486) DOI: 10.1038/mp.2008.96)
by: Bates, K., et al.
Published: (2009)

Cerebral amyloid-ß accumulation and deposition following traumatic brain injury-A narrative review and meta-analysis of animal studies
by: Bird, S., et al.
Published: (2016)

Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease
by: Gnjec, A., et al.
Published: (2008)

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)

Luteinizing Hormone Levels Are Positively Correlated with Plasma Amyloid-ß Protein Levels in Elderly Men
by: Verdile, Giuseppe, et al.
Published: (2008)

Characterising Interactions Between Amyloid-beta 42 and Amylin Peptide Heterodimers: A Molecular Simulation Approach
by: Sonar, Krushna Satish
Published: (2022)

Unveiling amyloid-β1–42 interaction with zinc in water and mixed hexafluoroisopropanol solution in Alzheimer’s disease
by: Ghani, Nur Syafiqah Abdul, et al.
Published: (2017)

Discovery and characterisation of anti-amyloid beta fibril antibodies from naive phage display VHH libraries
by: Fernandez Bonfante, Juan
Published: (2022)

The role of type 2 diabetes in neurodegeneration
by: Verdile, Giuseppe, et al.
Published: (2015)

Latrepirdine (Dimebon™) enhances autophagy and reduces intracellular GFP-A42 levels in yeast
by: Bharadwaj, P., et al.
Published: (2012)

Computational Elucidation Of Binding Interactions For Thicapa And Poet On Amyloid Beta 42 And Presenilin 1 In Treating Alzheimer’s Disease
by: Mohd Suhaimi, Ahmad Marwazi
Published: (2024)

Amyloid ß–associated cognitive decline in the absence of clinical disease progression and systemic illness
by: Harrington, K., et al.
Published: (2017)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aß-amyloid burden
by: Porter, T., et al.
Published: (2018)

Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor
by: Xie, Ling, et al.
Published: (2002)

Molecular simulation between amyloid beta (1-42), a Peptide associated with alzheimer disease, and zinc(ii) ion
by: Abdul Ghani, Nur Syafiqah
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qv9pna17h7sc5de393ua8tt2ef